Navigation Links
Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
Date:9/18/2008

BEIJING, Sept. 18 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading developer, producer and distributor of fulvic acid based nutrients for plants and animals in the People's Republic of China, today released a letter to shareholders from the Company's CEO and Chairman of the Board, Mr. Zishen Wu, summarizing some recent Company events and plans for the future.

Dear Shareholders:

I would like to update you on some recent developments and plans for the future at Yongye.

On September 11, 2008, a registration statement registering 18,967,646 shares of common stock was declared effective by the Securities and Exchange Commission. The registration statement included shares of common stock and shares of common stock underlying warrants that were sold to investors in two separate private placement transactions that were closed in April and September, respectively, which are now eligible for resale to the public. There were several institutional investors in the most recent round of financing, many of which had participated in the April financing. The length of the registration process was well within the 150-day time limit required in our April Securities Purchase Agreement, even though we delayed going effective until the September financing was closed. We expect that over time this will contribute to improved trading liquidity in our stock.

We plan to seek a listing on NASDAQ in the near future and feel that this is an important time to update investors on the company's current plans and outlook.

We believe that Yongye has an exceptionally bright future because of very strong demand for our products, our scalable distribution model, the planned expansion of our manufacturing capacity, and pipeline of promising new products. We experienced exceptional growth in revenues and improved profitability during the first half of 2008, and we foresee th
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
6. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
7. XTL Receives Staff Letter From NASDAQ
8. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
9. Pharmos Issues Letter to Shareholders
10. Coherent, Inc. Receives Expected Letter from NASDAQ
11. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., LONDON, November 30 ApaTech,...amed Europe,s fastest growing,Biotech/Pharmaceutic...oitte,2009 Technology Fast 500 for EMEA (Europe, M...king is based on a companies, five-year revenue gr...18% over this period. This,achievement places ApaT...
(Date:11/29/2009)...available in German . , The concept of conf...ics. The most famous example is that of quarks whi... Prof. Bella Lake from Helmholtz-Zentrum Berlin to...port for the first time an experimental realizatio...n a condensed matter system. , The concept of co...
(Date:11/27/2009)...URHAM, N.C., Nov. 27 Cromoz Inc., ...ater-soluble carbon nanotube-based cancer drug del...e carbon nanotubes, which have functional groups o...r drugs, was developed in partnership with the Ind...on nanotubes serves as a drug delivery vehicle wit...
(Date:11/27/2009)... A mechanised blue dye test alternative is...ality assurance one step closer for pharma-compani...ting machine developed by Sepha for use with bl...everal local and global pharma-companies such as S...assurance and productivity improvements on the pac...
Breaking Biology Technology:ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Spinons -- confined like quarks 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3
...27 Human Genome Sciences, Inc. (Nasdaq: HGSI ... Annual Citi Biotech Day will be webcast and may b...tp://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO...or management team will present a corporate overvi...Time. , , Investors interested in listening to th...
...st Pharmaceutical Partners, Inc. (Nasdaq: CPRX )...censes, develops and commercializes prescription d...ported financial results for the fourth quarter an...e significant progress in 2008," said Patrick J. M...ceutical Partners. "During the year, we initiated...
... Coach allows users to track their cholesterol and...ting together an action plan for diet, exercise an...h cholesterol. , Melbourn...ls has just released Cholesterol Coach onto the iT...sterolaemia is a leading cause of heart disease an...
Other Biology Technology:Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 2Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 3Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 4Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 5Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 6First Application to Fight High Cholesterol Launches on the iPhone and iPod Touch 2
(Date:11/30/2009)...ugural Global Conference on Systems & Enterprises ...on, DC, focuses on the convergence of complex larg...ance to society. , The goal of the conferenc...und targeted complex systems, examined by domain, ...Critical Infrastructure Systems, including Intelli...
(Date:11/30/2009)...research is the virus,s exquisite specialisation f...ional tools, like the humble lab mouse, can delive...hers writing in BioMed Central,s open access Jour...this problem by creating a mouse that has key feat...HIV. , George Kassiotis, from the Division of Im...
(Date:11/30/2009)...nd odorless radioactive gas that is produced by th... of uranium decay and is found in trace amounts na...r as well as building materials, plants, animals, ...pressed as the amount of radiation that would be e...of air; thus the units are picocuries per liter (p...
Breaking Biology News(10 mins):First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2A reductionist approach to HIV research 2Health Physics Society recommends considering action for indoor radon below current guidelines 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 1Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 4Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 5Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 6Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 7Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 8Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 9Study reveals new role of vitamin C in skin protection 56591 1Study reveals new role of vitamin C in skin protection 56591 2UAB researchers find TB prevention therapy is cost effective option 56588 1UAB researchers find TB prevention therapy is cost effective option 56588 2
...chnic Institute have developed tools to help solve...stem cell research how to quickly test stem cell ...reate a large supply of healthy, viable stem cells...researchers have created methods to study millions...microscope slide. The techniques enable thousands ...
...ndation has awarded Rutgers University scientists ...utreach beyond the borders of the university to re...he new NSF funding build upon the Waksman Student ...h more than 1,500 high school students and 72 teac...in molecular biology research. , Professors Willi...
...ilt greenhouse held more members of a rare species...e wild., This unusual bounty was the result of res...l student in the biological sciences department, w... McCauley., The species is called the giant whorle...overed in 1892 in Tennessee but was thought to be ...
Other Biology News:Putting stem cell research on the fast track 2Putting stem cell research on the fast track 3Putting stem cell research on the fast track 4Rutgers' high school outreach gets $3 million boost from NSF 2Student study bolsters case for adding a rare sunflower to the endangered species list 2
Xpression Primer from PREMIER Biosoft International
HybriWell™ hybridization sealing system, 22 mm x 22 mm chamber, 0.15 mm deep *set of 100* from Molecular Probes (Invitrogen)
Equine IL-6, Unconjugated from R&D Systems
Feline IL-2, Unconjugated from R&D Systems
Biology Products: